Blockchain Registration Transaction Record

GeoVax to Showcase Vaccine and Cancer Therapy Advances at Emerging Growth Conference

GeoVax Labs to present updates on GEO-MVA, GEO-CM04S1, and Gedeptin® at Emerging Growth Conference, showcasing progress in vaccines and cancer therapies.

This news is significant as it highlights GeoVax's contributions to addressing critical health challenges, including infectious diseases and cancer. The advancements in their vaccine and therapy programs could lead to more effective treatments and prevention strategies, impacting global health security and patient care. The company's focus on immunocompromised individuals and solid tumors addresses unmet medical needs, offering hope for improved outcomes in these vulnerable populations.